N/A N=30 Prevention

Stroke Education Intervention Trial - Pilot

Ischemic Stroke · Intracranial Hemorrhage · Transient Ischemic Attack

Bottom Line

View on ClinicalTrials.gov: NCT01115660 ↗

Enrolled (actual)

Serious AEs

—

Results posted

Jan 2013

Primary outcome: Primary: Feasibility of Intervention (Ability to Reach Patients at 3 Months) — 16; 10 number of patients contacted

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: stroke education (Behavioral)
Age: Adult, Older Adult · 19+ yrs
Sex: All
Sponsor: Duke University
Primary completion: Jun 2011

Outcome Measures

Outcome	Result	p-value
PRIMARY Feasibility of Intervention (Ability to Reach Patients at 3 Months)	16; 10	—
SECONDARY Follow up Appointment With MD	15; 7	—

Summary

The objectives of the trial of a medication-coach program for patients with stroke or transient ischemic attack are to pilot test the study design, the intervention components and the data collection forms and refine them for a larger trial whose goal will be to improve long-term adherence to stroke prevention medications.

Eligibility Criteria

Inclusion Criteria

Patients at Wake Forest University Baptist Medical Center (WFUBMC) over age 18
Diagnosed with acute ischemic stroke, transient ischemic attack or intracranial hemorrhage
provide consent to participate

Exclusion Criteria

discharged to nursing home, acute rehabilitation center, inpatient hospice, or other acute hospital
homeless
non-English speakers
patient and proxy unable to participate in telephone conversation

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01115660). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.